共 50 条
- [1] Improvements in IBS-Related Quality of Life in a Randomized, Controlled Repeat Treatment Trial (TARGET 3) of Rifaximin for IBS-D[J]. GASTROENTEROLOGY, 2015, 148 (04) : S663 - S663Cash, Brooks D.Lembo, AnthonyAggarwal, KavitaBortey, EnochPaterson, CraigForbes, William P.
- [2] RIFAXIMIN FOR IMPROVING ABDOMINAL PAIN AND BLOATING SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) USING MODIFIED DEFINITIONS OF PAIN RESPONSE[J]. GASTROENTEROLOGY, 2019, 156 (06) : S92 - S93Lacy, Brian E.Heimanson, ZeevPimentel, Mark
- [3] Rifaximin for Improving Abdominal Pain and Bloating Symptoms in Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) Using Modified Definitions of Pain Response[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S263 - S263Lacy, Brian E.Heimanson, ZeevPimentel, Mark
- [4] Rifaximin for improving abdominal pain and bloating symptoms in patients with irritable bowel syndrome with diarrhea (IBS-D) using modified definitions of pain response[J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31Lacy, B.Heimanson, Z.Pimente, M.
- [5] Enduring Effects Following a Course of Rifaximin Therapy in Patients With IBS-D: Incremental Benefit Upon Repeat Treatment[J]. GASTROENTEROLOGY, 2015, 148 (04) : S655 - S655Lacy, Brian E.Pimentel, MarkChang, LinBarrett, Andrew C.Yu, JingBortey, EnochPaterson, CraigForbes, William P.
- [6] Characterization of Abdominal Pain Response to Rifaximin in Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D), by Baseline Pain Severity[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S251 - S251Lembo, AnthonyHeimanson, ZeevCash, Brooks D.
- [7] Safety and Tolerability of Rifaximin in a Repeat Treatment Study in Subjects With IBS-D: Results From TARGET 3[J]. GASTROENTEROLOGY, 2015, 148 (04) : S657 - S658Lembo, AnthonyGolden, PamelaBarrett, Andrew C.Bortey, EnochPaterson, CraigForbes, William P.
- [8] CHARACTERIZATION OF ABDOMINAL PAIN RESPONSE TO RIFAXIMIN IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D), BY BASELINE PAIN SEVERITY[J]. GASTROENTEROLOGY, 2019, 156 (06) : S775 - S775Lembo, AnthonyHeimanson, ZeevCash, Brooks D.
- [9] Characterization of abdominal pain response to rifaximin in patients with irritable bowel syndrome with diarrhea (IBS-D), by baseline (BL) pain severity[J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31Lembo, A.Heimanson, Z.Cash, B. D.
- [10] EFFICACY OF RIFAXIMIN ON BLOATING IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D): A POOLED ANALYSIS OF THREE PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS[J]. GASTROENTEROLOGY, 2018, 154 (06) : S498 - S499Lacy, Brian E.Pimentel, MarkChang, ChristopherHeimanson, ZeevLembo, Anthony J.